Risk stratification for trimethoprim-sulfamethoxazole resistance in community-acquired, uncomplicated urinary tract infections
| Autor: | Philippe A. Mentler, Bryan R. Kuhn, Guneet Gandhi |
|---|---|
| Rok vydání: | 2006 |
| Předmět: |
Pharmacology
medicine.medical_specialty business.industry Health Policy Sulfamethoxazole Urinary system Trimethoprim Resistance Anti-Infective Agents Urinary Trimethoprim Disease control Community-Acquired Infections Risk Factors Drug Resistance Multiple Bacterial Trimethoprim Sulfamethoxazole Drug Combination Urinary Tract Infections Risk stratification medicine Humans Female Emergency Service Hospital Intensive care medicine business Empiric treatment medicine.drug |
| Zdroj: | American Journal of Health-System Pharmacy. 63:1588-1590 |
| ISSN: | 1535-2900 1079-2082 |
| DOI: | 10.2146/ajhp060177 |
| Popis: | Urinary tract infections (UTIs) account for over 1.8 million ED visits yearly in the United States, according to advance data from the Centers of Disease Control and Prevention.[1][1] The Infectious Diseases Society of America (IDSA) recommends trimethoprim–sulfamethoxazole as empiric treatment |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|